LC
WST icon

Lindbrook Capital’s West Pharmaceutical WST Stock Holding History

Lindbrook Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$45.9K Sell
205
-15
-7% -$4.13K ﹤0.01% 1050
2024
Q4 		$72.1K Buy
220
+65
+42% +$20.5K 0.01% 665
2024
Q3 		$46.5K Sell
155
-63
-29% -$19.3K ﹤0.01% 855
2024
Q2 		$71.8K Sell
218
-19
-8% -$6.71K 0.01% 652
2024
Q1 		$93.8K Buy
237
+2
+0.9% +$740 0.01% 553
2023
Q4 		$82.7K Buy
235
+74
+46% +$26.2K 0.01% 579
2023
Q3 		$60.4K Buy
161
+2
+1% +$773 0.01% 617
2023
Q2 		$60.8K Sell
159
-22
-12% -$7.86K 0.01% 638
2023
Q1 		$62.7K Buy
181
+106
+141% +$31K 0.01% 609
2022
Q4 		$17.7K Sell
75
-40
-35% -$9.48K ﹤0.01% 1125
2022
Q3 		$28K Buy
115
+47
+69% +$14.3K ﹤0.01% 850
2022
Q2 		$21K Buy
68
+14
+26% +$4.55K ﹤0.01% 956
2022
Q1 		$22K Sell
54
-1
-2% -$391 ﹤0.01% 973
2021
Q4 		$26K Sell
55
-4
-7% -$1.72K ﹤0.01% 934
2021
Q3 		$25K Buy
59
+9
+18% +$3.79K 0.01% 667
2021
Q2 		$18K Buy
50
+3
+6% +$991 ﹤0.01% 831
2021
Q1 		$13K Buy
47
+15
+47% +$4.29K ﹤0.01% 926
2020
Q4 		$9K Hold
32
– – ﹤0.01% 968
2020
Q3 		$9K Buy
32
+6
+23% +$1.59K ﹤0.01% 886
2020
Q2 		$6K Hold
26
– – ﹤0.01% 1045
2020
Q1 		$4K Hold
26
– – ﹤0.01% 1124
2019
Q4 		$4K Hold
26
– – ﹤0.01% 1177
2019
Q3 		$4K Hold
26
– – ﹤0.01% 1131
2019
Q2 		$3K Hold
26
– – ﹤0.01% 1179
2019
Q1 		$2K Hold
26
– – ﹤0.01% 1258
2018
Q4 		$2K Buy
+26
New +$2.82K ﹤0.01% 1207

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Lindbrook Capital's WST Position: Q1 2025 in Review

Lindbrook Capital reduced its West Pharmaceutical (WST) stake by 6.8% in Q1 2025, selling an estimated $4.13K and leaving 205 shares worth $45.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1050.

Lindbrook Capital first reported a position in WST in Q4 2018 and has held it in 26 quarters since. The position peaked at $93.8K in Q1 2024. 714 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Lindbrook Capital held 205 shares of West Pharmaceutical worth $45.9K as of Q1 2025.
  • Lindbrook Capital sold 15 West Pharmaceutical shares in Q1 2025, an estimated $4.13K.
  • West Pharmaceutical made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1050 holding.
  • Lindbrook Capital first reported a position in West Pharmaceutical in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's West Pharmaceutical position peaked at $93.8K in Q1 2024.
  • 714 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.